Abstract
Summary
Refrigeration of angiotensin II-I131 in vitro with human sera from normotensive, untreated primary benign hypertensive and secondary renal hypertensive subjects demonstrated that greater quantities of angiotensin II-I131 were degraded by the untreated primary benign hypertensive patients than by the normotensive or secondary renal hypertensive patients. Evidence for presence of a serum factor (or factors) enhancing angiotensin II-I131 degradation and for a heat labile inhibitor has been advanced. The greater in vitro degradation of angiotensin II-I131 by untreated primary benign hypertensive patients than by normotensive subjects contrasts with the in vivo turnover rates.
Get full access to this article
View all access options for this article.
